This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Joel S. Marcus, Chairman, Chief Executive Officer, And Founder Of Alexandria Real Estate Equities, Inc. And Alexandria Venture Investments, Elected To The Board Of Directors Of The Foundation For The National Institutes Of Health

PASADENA, Calif., July 10, 2012 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE) is pleased to announce that Chairman, Chief Executive Officer, and Founder, Joel S. Marcus, was unanimously elected to the Board of Directors of the Foundation for the National Institutes of Health (FNIH). Among the board members' responsibilities are helping guide the FNIH's mission and purpose; ensuring effective organizational planning; ensuring adequate resources and managing them effectively; reviewing, monitoring, and strengthening the FNIH's programs and services; and enhancing the FNIH's public standing. Other board members include former Chairman and Chief Executive Officer of Glaxo Inc., Charles A. Sanders, M.D.; James H. Donovan, Partner at Goldman Sachs & Company; Freda C. Lewis-Hall, M.D., FAPA, Chief Medical Officer and Executive Vice President of Pfizer Inc.; Paul L. Herrling, Ph.D., Chairman of the Novartis Institute for Tropical Diseases; Steven M. Paul, M.D., former Executive Vice President of Science and Technology and President of the Lilly Research Laboratories of Eli Lilly and Company; and Ellen V. Sigal, Ph.D., Chairperson and Founder of Friends of Cancer Research. Mr. Marcus began his term May 16, 2012.

"The wealth of knowledge Joel possesses will be an asset to the FNIH," stated Charles A. Sanders, MD, Chairman of the FNIH. "He will diversify the knowledge base of our directors and makes a wonderful addition to our board."

"Joel has a long standing commitment to science and a deep understanding of what is needed to foster and encourage creativity and innovation in scientific research," noted Mrs. William McCormick Blair, Jr., FNIH board secretary.

"Having worked closely with a plethora of public and private entities within the broad and diverse life science community for nearly 30 years, I have personally witnessed the critical role that strategic funding for innovative research plays in the development of novel breakthrough discoveries that prevent illness, save lives, improve the quality of life, and significantly reduce the economic burden of disease on society," said Mr. Marcus. "As the global leader in cutting-edge life science research, our nation must continue its commitment to fund this mission-critical, world-class research engine, which is both enormously and positively impactful on human health as well as a major generator of high-quality jobs. I look forward to working alongside my colleagues as a board member of the FNIH to carry out this mission efficiently and effectively."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
YHOO $36.13 -1.10%
AAPL $95.33 1.80%
FB $117.85 -0.61%
GOOG $696.00 -0.32%
TSLA $233.55 -3.40%


Chart of I:DJI
DOW 17,770.29 -120.87 -0.68%
S&P 500 2,064.80 -16.63 -0.80%
NASDAQ 4,775.4250 -42.1690 -0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs